Stocks

us stock futures

US Stock Futures Inch Up Amid Hot Inflation Data

On Thursday, US stock futures slightly advanced in the trading market amid the soaring American inflation data.  Accordingly, the Dow futures slightly rose 0.02% or 7.00 points to $35,999.00 per share.  Similarly, the contracts in the S&P 500 advanced 0.15% or 7.00 points to $4,649.00 per share.  At the same time, the Nasdaq futures elevated …

US Stock Futures Inch Up Amid Hot Inflation Data Read More »

TMN - RH

Asia-Pacific Stocks Mixed; Chinese Trade Data in Focus

On Monday, Asia-Pacific stocks struggled for direction as investors reacted to the Chinese trade data released last Saturday.  Accordingly, China’s exports surged to 27.10% from a year ago in October, surpassing the market estimate of 24.10%.  Consequently, its imports posted at 20.60%, lower than the projected 25.00%.  Overall, the trade balance stood at $84.54 billion, …

Asia-Pacific Stocks Mixed; Chinese Trade Data in Focus Read More »

TMN - novavax

Novavax Stocks Rebound after Reporting Q3 Earnings Results

Stocks of Novavax Inc. rebounded in after-hours trading after it reported its third-quarter earnings results.  Accordingly, the biotech company surged 6.46% or 11.59 points to $191.00 per share. It also reversed its sharp plunge of 8.09% or 15.79 points to $179.41 per share on Thursday.  In the latest quarterly report, Novavax revenue edged up 14.00% …

Novavax Stocks Rebound after Reporting Q3 Earnings Results Read More »

credit suisse

Credit Suisse Stocks Decline as it Pares Investment Banking

On Thursday, stocks of Credit Suisse skidded as it announced to shift focus from its investment bank to its wealth-management business.  The Swiss company plummeted 0.40% or 0.04 points to $10.80 per share. At the same time, it followed its Wednesday drop of 1.69% to $10.84 per share.  Accordingly, Credit Suisse will leave its prime …

Credit Suisse Stocks Decline as it Pares Investment Banking Read More »

pfizer

Pfizer Stocks Rise as it Lifts COVID Vaccine Sales Outlook

In after-hours trading, stocks of Pfizer jumped as it boosted its full-year sales forecast for its Covid-19 vaccine after posting better than expected third-quarter results.  Accordingly, the pharmaceutical firm climbed 0.75% or 0.34 points to $45.79 per share.  Subsequently, it followed its Tuesday hike of 4.15% or 1.81 points to $45.45 per share.  Moreover, Pfizer …

Pfizer Stocks Rise as it Lifts COVID Vaccine Sales Outlook Read More »